stemcell therapy use stem cells treat prevent disease established therapy using stem cells hematopoietic stem cell usually takes form bonemarrow transplantation cells also derived umbilical cord blood research underway develop various sources stem cells well apply stemcell treatments neurodegenerative conditions diabetes heart disease stemcell therapy become controversial following developments ability scientists isolate culture embryonic stem cells create stem cells using somatic cell nuclear transfer use techniques create induced pluripotent stem cells controversy often related abortion politics human cloning additionally efforts market treatments based transplant stored umbilical cord blood controversial years hematopoietic stem cell transplantation hsct used treat people conditions leukaemia lymphoma widely practiced form stemcell chemotherapy growing cells killed cytotoxic agents agents however discriminate leukaemia neoplastic cells hematopoietic stem cells within bone marrow side effect conventional chemotherapy strategies stemcell transplant attempts reverse donors healthy bone marrow reintroduces functional stem cells replace cells lost hosts body treatment transplanted cells also generate immune response helps kill cancer cells process go far however leading graft vs host disease serious side effect another stemcell therapy called prococvhymal conditionally approved canada management acute graftvshost disease children unresponsive allogenic stem therapy based mesenchymal stem cells mscs derived bone marrow adult donors mscs purified marrow cultured packaged doses derived single donor doses stored frozen fda approved five hematopoietic stemcell products derived umbilicalcord blood treatment blood immunological european medicines agency recommended approval limbal stem cells people severe limbal stem cell deficiency due burns stem cells studied number reasons molecules exosomes released stem cells also studied effort make addition functions cells paracrine soluble factors produced stem cells known stem cell secretome found another mechanism stem cellbased therapies mediate effects degenerative autoimmune inflammatory used research treatment applications large numbers highquality stem cells needed thus necessary develop culture systems produce pure populations tissuespecific stemcells vitro without loss stemcell potential two main approaches taken purpose twodimensional threedimensional cell cell culture two dimensions routinely performed thousands laboratories worldwide past four decades twodimensional platforms cells typically exposed solid rigid flat surface basal side liquid apical surface inhabiting twodimensional rigid substrate requires dramatic adaption surviving cells lack extracellular matrix unique cell type may alter cell metabolism reduce threedimensional cell culture systems may create biomimicking microenvironment stem cells resembling native threedimensional extracellular matrix ecm advanced biomaterials significantly contributed threedimensional cell culture systems recent decades unique complex biomaterials proposed improving stemcell proliferation controlled differentiation among nanostructured biomaterials particular interest advantage high surfacetovolume ratio mimic physical biological features natural ecm research conducted effects stem cells animal models brain degeneration parkinsons disease amyotrophic lateral sclerosis alzheimers preliminary studies related multiple sclerosis phase trial found significantly improved outcomes mesenchymal stem cell treated patients compared receiving sham january fda approved first clinical trial investigational stem cell therapy restore lost brain cells people advanced parkinsons healthy adult brains contain neural stem cells divide maintain general stemcell numbers become progenitor cells healthy adult laboratory animals progenitor cells migrate within brain function primarily maintain neuron populations olfaction sense smell pharmacological activation endogenous neural stem cells reported induce neuroprotection behavioral recovery adult rat models neurological stroke traumatic brain injury lead cell death characterized loss neurons oligodendrocytes within brain clinical animal studies conducted use stem cells cases spinal cord smallscale study individuals year older aging frailty showed intravenous treatment mesenchymal stem cells msc healthy young donors showed significant improvements physical performance measures msc helps blockade inflammation decreasing causing effects frailty stem cells studied people severe heart work bodoeckehard discredited identifying hundreds factual among several clinical trials reporting adult stem cell therapy safe effective actual evidence benefit reported preliminary clinical trials achieved modest improvements heart function following use bone marrow stem cell stemcell therapy treatment myocardial infarction usually makes use autologous bonemarrow stem cells types adult stem cells may used adiposederived stem possible mechanisms recovery studies autologous bonemarrow stem cells ventricular function found contain hundreds critics report reports five underlying trials seemed used many cases whether randomized merely observational accepterversusrejecter contradictory reports trial one pair reports identical baseline characteristics final results presented two publications respectively randomized trial observational study reports required impossible negative standard deviations subsets people contained fractional subjects negative nyha classes overall many people reported receiving stem cells trials number stem cells processed hospitals laboratory time university investigation closed without reporting reopened july metaanalysis stem cell therapy using bonemarrow stem cells heart disease revealed discrepancies published clinical trial reports whereby studies higher number discrepancies showed increase effect another metaanalysis based intrasubject data randomized trials unable find significant benefits stem cell therapy primary endpoints major adverse events increase heart function measures concluding time trial used randomized doubleblind placebocontrolled trial design concluded bone marrow mononuclear cells administration improve recovery lv function years people myocardial accordingly trial conducted medical centers germany norway reported trial result support use nucleated bmcs patients stemi moderately reduced furthermore trial also meet secondary mri leading conclusion intracoronary bone marrow stem cell therapy offer functional clinical specificity human immunecell repertoire allows human body defend rapidly adapting antigens however immune system vulnerable degradation upon pathogenesis disease critical role plays overall defense degradation often fatal organism whole diseases hematopoietic cells diagnosed classified via subspecialty pathology known hematopathology specificity immune cells allows recognition foreign antigens causing challenges treatment immune disease identical matches donor recipient must made successful transplantation treatments matches uncommon even firstdegree relatives research using hematopoietic adult stem cells embryonic stem cells provided insight possible mechanisms methods treatment many fully mature human red blood cells may generated ex vivo hematopoietic stem cells hscs precursors red blood cells process hscs grown together stromal cells creating environment mimics conditions bone marrow natural site redbloodcell growth erythropoietin growth factor added coaxing stem cells complete terminal differentiation red blood research technique potential benefits gene therapy blood transfusion topical medicine scientists kings college london discovered way cultivate complete tooth able grow bioengineered teeth standalone laboratory researchers confident tooth regeneration technology used grow live teeth people theory stem cells taken patient could coaxed lab turning tooth bud implanted gums give rise new tooth would expected grown time three fuse jawbone release chemicals encourage nerves blood vessels connect process similar happens humans grow original adult teeth many challenges remain however stem cells could choice replacement missing teeth heller reported success regrowing cochlea hair cells use embryonic stem review looked hearing regeneration regenerative medicine stem cellderived otic progenitors potential greatly improve since researchers successfully transplanted corneal stem cells damaged eyes restore vision sheets retinal cells used team harvested aborted fetuses people find objectionable sheets transplanted damaged cornea stem cells stimulate renewed repair eventually restore latest development june researchers queen victoria hospital sussex england able restore sight forty people using technique group led sheraz daya able successfully use adult stem cells obtained patient relative even cadaver rounds trials people type diabetes lose function insulinproducing beta cells within recent experiments scientists able coax embryonic stem cell turn beta cells lab theory beta cell transplanted successfully able replace malfunctioning ones diabetic use mesenchymal stem cells mscs derived adult stem cells preliminary research potential orthopedic applications bone muscle trauma cartilage repair osteoarthritis intervertebral disc surgery rotator cuff surgery musculoskeletal disorders among areas orthopedic research uses mscs include tissue engineering regenerative stem cells also used stimulate growth human tissues adult wounded tissue often replaced scar tissue characterized skin disorganized collagen structure loss hair follicles irregular vascular structure case wounded fetal tissue however wounded tissue replaced normal tissue activity stem possible method tissue regeneration adults place adult stem cell seeds inside tissue bed soil wound bed allow stem cells stimulate differentiation tissue bed cells method elicits regenerative response similar fetal woundhealing adult scar tissue researchers still investigating different aspects soil tissue conducive general healing capabilities stem cells gained interest treatment cutaneous wounds skin destruction immune system hiv driven loss cells peripheral blood lymphoid tissues viral entry cells mediated interaction cellular chemokine receptor common subsequent viral replication requires cellular gene expression processes activated cells primary targets productive hiv recently scientists investigating alternative approach treating based creation diseaseresistant immune system transplantation autologous genemodified hematopoietic stem progenitor cells stem cells thought mediate repair via five primary mechanisms providing antiinflammatory effect homing damaged tissues recruiting cells endothelial progenitor cells necessary tissue growth supporting tissue remodeling scar formation inhibiting apoptosis differentiating bone cartilage tendon ligament enrich blood supply damaged areas consequently promote tissue regeneration plateletrich plasma could used conjunction stem cell efficacy stem cell populations may also affected method delivery instance regenerate bone stem cells often introduced scaffold produce minerals necessary generation functional stem cells also shown low immunogenicity due relatively low number mhc molecules found surface addition found secrete chemokines alter immune response promote tolerance new tissue allows allogeneic treatments performed without high rejection ability grow functional adult tissues indefinitely culture directed differentiation creates new opportunities drug research researchers able grow differentiated cell lines test new drugs cell type examine possible interactions vitro performing vivo studies critical development drugs use veterinary research possibilities speciesspecific interactions hope cell lines available research use reduce need research animals used effects human tissue vitro provide insight normally known animal testing stem cells explored use conservation efforts spermatogonial stem cells harvested rat placed mouse host fully mature sperm produced ability produce viable offspring currently research underway find suitable hosts introduction donor spermatogonial stem cells becomes viable option conservationists sperm produced high genetic quality individuals die reaching sexual maturity preserving line would otherwise stem cells intended regenerative therapy generally isolated either patients bone marrow adipose mesenchymal stem cells differentiate cells make bone cartilage tendons ligaments well muscle neural progenitor tissues main type stem cells studied treatment diseases affecting number stem cells transplanted damaged tissue may alter efficacy treatment accordingly stem cells derived bone marrow aspirates instance cultured specialized laboratories expansion millions although adiposederived tissue also requires processing prior use culturing methodology adiposederived stem cells extensive bone marrowderived thought bonemarrowderived stem cells preferred bone cartilage ligament tendon repair others believe less challenging collection techniques multicellular microenvironment already present adiposederived stem cell fractions make latter preferred source autologous new sources mesenchymal stem cells researched including stem cells present skin dermis interest ease harvested minimal risk hematopoietic stem cells also discovered travelling blood stream possess equal differentiating ability mesenchymal stem cells noninvasive harvesting recent interest use extra embryonic mesenchymal stem cells research underway examine differentiating capabilities stem cells found umbilical cord yolk sac placenta different animals stem cells thought differentiating ability adult counterparts including ability readily form tissues endodermal ectodermal widespread controversy use human embryonic stem cells controversy primarily targets techniques used derive new embryonic stem cell lines often requires destruction blastocyst opposition use human embryonic stem cells research often based philosophical moral religious stem cell research involve destruction human embryo research involves adult stem cells amniotic stem cells induced pluripotent stem cells january us food drug administration gave clearance geron corporation initiation first clinical trial embryonic stemcellbased therapy humans trial aimed evaluate drug embryonic stem cellderived oligodendrocyte progenitor cells people acute spinal cord injury trial discontinued november company could focus therapies current environment capital scarcity uncertain economic biotechnology regenerative medicine company biotime amex btx acquired gerons stem cell assets stock transaction aim restarting clinical scientists reported mscs transfused immediately within hours post thawing may show reduced function show decreased efficacy treating diseases compared mscs log phase cell growth fresh cryopreserved mscs brought back log phase cell growth invitro culture administration reculturing mscs help recovering shock cells get freezing thawing various msc clinical trials used cryopreserved product immediately post thaw failed compared clinical trials used fresh research conducted horses dogs cats led development stem cell treatments veterinary medicine target wide range injuries diseases myocardial infarction stroke tendon ligament damage osteoarthritis osteochondrosis muscular dystrophy large animals well investigation cellbased therapeutics generally reflects human medical needs high degree frequency severity certain injuries racehorses put veterinary medicine forefront novel regenerative companion animals serve clinically relevant models closely mimic human veterinary applications stem cell therapy means tissue regeneration largely shaped research began use adultderived mesenchymal stem cells treat animals injuries defects affecting bone cartilage ligaments andor two main categories stem cells used treatments allogeneic stem cells derived genetically different donor within autologous mesenchymal stem cells derived patient prior use various third category xenogenic stem cells stem cells derived different species used primarily research purposes especially human bone unique welldocumented natural healing process normally sufficient repair fractures common injuries misaligned breaks due severe trauma well treatments like tumor resections bone cancer prone improper healing left natural process alone scaffolds composed natural artificial components seeded mesenchymal stem cells placed defect within four weeks placing scaffold newly formed bone begins integrate old bone within weeks full union studies necessary fully characterize use cellbased therapeutics treatment bone fractures stem cells used treat degenerative bone diseases normally recommended treatment dogs disease remove head femur degeneration progressed recently mesenchymal stem cells injected directly head femur success bone regeneration also pain autologous stem cellbased treatments ligament injury tendon injury osteoarthritis osteochondrosis subchondral bone cysts commercially available practicing veterinarians treat horses since united states since united kingdom autologous stem cell based treatments tendon injury ligament injury osteoarthritis dogs available veterinarians united states since privately owned horses dogs treated autologous adiposederived stem cells efficacy treatments shown doubleblind clinical trials dogs osteoarthritis hip elbow horses tendon race horses especially prone injuries tendon ligaments conventional therapies unsuccessful returning horse full functioning potential natural healing guided conventional treatments leads formation fibrous scar tissue reduces flexibility full joint movement traditional treatments prevented large number horses returning full activity also high incidence reinjury due stiff nature scarred tendon introduction bone marrow adipose derived stem cells along natural mechanical stimulus promoted regeneration tendon tissue natural movement promoted alignment new fibers tendocytes natural alignment found uninjured tendons stem cell treatment allowed horses return full duty also greatly reduced reinjury rate threeyear use embryonic stem cells also applied tendon repair embryonic stem cells shown better survival rate tendon well better migrating capabilities reach areas damaged tendon overall repair quality also higher better tendon architecture collagen formed also tumor formation seen threemonth experimental period longterm studies need carried examine longterm efficacy risks associated use embryonic stem similar results found small osteoarthritis main cause joint pain animals humans horses dogs frequently affected arthritis natural cartilage regeneration limited different types mesenchymal stem cells additives still researched find best type cell method longterm adiposederived mesenchymal cells currently often used stem cell treatment osteoarthritis noninvasive harvesting recently developed noninvasive technique developed easier clinical use dogs receiving treatment showed greater flexibility joints less stem cells successfully used ameliorate healing heart myocardial infarction dogs adipose bone marrow derived stem cells removed induced cardiac cell fate injected heart heart found improved contractility reduction damaged area four weeks stem cells different trial underway patch made porous substance onto stem cells seeded order induce tissue regeneration heart defects tissue regenerated patch well incorporated heart tissue thought due part improved angiogenesis reduction inflammation although cardiomyocytes produced mesenchymal stem cells appear contractile treatments induced cardiac fate cells transplanting greater success creating contractile heart recent research european ntrack research project aims demonstrate multimodal nanoparticles structurally functionally track stem cell muscle regeneration therapy idea label stem cells gold nanoparticles fully characterised uptake functionality safety labelled stem cells injected injured muscle tracked using imaging however system still needs demonstrated lab scale spinal cord injuries one common traumas brought veterinary spinal injuries occur two ways trauma primary mechanical damage secondary processes like inflammation scar formation days following trauma cells involved secondary damage response secrete factors promote scar formation inhibit cellular regeneration mesenchymal stem cells induced neural cell fate loaded onto porous scaffold implanted site injury cells scaffold secrete factors counteract secreted scar forming cells promote neural regeneration eight weeks later dogs treated stem cells showed immense improvement treated conventional therapies dogs treated stem cells able occasionally support weight seen dogs undergoing conventional study evaluate treatment experimentally induced ms dogs using laser activated nonexpanded adipose derived stem cells results showed amelioration clinical signs time confirmed resolution previous lesions mri positive migration injected cells site lesion increased remyelination detected myelin basic proteins positive differentiation positive oligodendrocytes prevented glial scar formation restored axonal treatments also clinical trials repair regenerate peripheral nerves peripheral nerves likely damaged effects damage widespread seen injuries spinal cord treatments currently clinical trials repair severed nerves early success stem cells induced neural fate injected severed nerve within four weeks regeneration previously damaged stem cells completely formed nerve bundles stem cells also clinical phases treatment ophthalmology hematopoietic stem cells used treat corneal ulcers different origin several horses ulcers resistant conventional treatments available quickly responded positively stem cell treatment stem cells also able restore sight one eye horse retinal detachment allowing horse return daily late early initial wave companies clinics offering stem cell therapy substantiating health claims regulatory second wave companies clinics emerged usually located developing countries medicine less regulated offering stem cell therapies medical tourism like first wave companies clinics made similar strong unsubstantiated claims mainly clinics united states mexico thailand india south research indicated stem cell clinics us alone selling generally unproven therapies wide array medical conditions almost every state altering dynamic stem cell tourism fda sent warning letter stemgenex biologic laboratories san diego marketed service took body fat people processed mixtures said contained various forms stem cells administered back person inhalation intravenously infusion spinal cords company said treatment useful many chronic lifethreatening costs stem cell therapies range widely clinic condition cell type commonly range insurance cover stem cell injections clinics patients often use online us federal trade commission found health centers individual physician making unsubstantiated claims stem cell therapies forced refunds fda filed suit two stem cell clinic firms around time seeking permanent injunctions marketing use unapproved adipose stem cell although according nih stem cell treatments approved agency recommends use mscs stem cell clinics began marketing unproven nonfdaapproved stem cells exosomes fda took prompt action sending letters firms ftc also warned stem cell firm misleading httpsenwikipediaorgwikistemcelltherapy